Tocilizumab use in patients with moderate to severe COVID‐19: A retrospective cohort study

Sridhar Chilimuri; Haozhe Sun; Ahmed Alemam; Kyoung‐Sil Kang; Peter Lao; Nikhitha Mantri; Lawrence Schiller; Myroslava Sharabun; Elona Shehi; Jairo Tejada; Alla Yugay; Suresh Kumar Nayudu

doi:10.1111/jcpt.13303

Back

Tocilizumab use in patients with moderate to severe COVID‐19: A retrospective cohort study

Journal article

Open access

Peer reviewed

Tocilizumab use in patients with moderate to severe COVID‐19: A retrospective cohort study

Sridhar Chilimuri, Haozhe Sun, Ahmed Alemam, Kyoung‐Sil Kang, Peter Lao, Nikhitha Mantri, Lawrence Schiller, Myroslava Sharabun, Elona Shehi, Jairo Tejada, …

Journal of clinical pharmacy and therapeutics, Vol.46(2), pp.440-446

04/2021

DOI: https://doi.org/10.1111/jcpt.13303

PMID: 33098139

Files and links (1)

url

https://doi.org/10.1111/jcpt.13303View

Published (Version of record) Open

Metrics

1 Record Views

See more details

Details

Title: Tocilizumab use in patients with moderate to severe COVID‐19: A retrospective cohort study
Creators - without role: Sridhar Chilimuri - Mount Sinai Health System
Haozhe Sun - Mount Sinai Health System
Ahmed Alemam - Mount Sinai Health System
Kyoung‐Sil Kang - Icahn School of Medicine at Mount Sinai
Peter Lao - Mount Sinai Health System
Nikhitha Mantri - Mount Sinai Health System
Lawrence Schiller - Mount Sinai Health System
Myroslava Sharabun - Mount Sinai Health System
Elona Shehi - Mount Sinai Health System
Jairo Tejada - Mount Sinai Health System
Alla Yugay - Mount Sinai Health System
Suresh Kumar Nayudu - Mount Sinai Health System
Publication Details: Journal of clinical pharmacy and therapeutics, Vol.46(2), pp.440-446
Identifiers: 9924189308331
Academic Unit: King Khalid University
Language: English
Resource Type: Journal article